NVAX vs OCUL Stock Comparison
Compare NVAX vs OCUL on performance, valuation, growth, fundamentals, momentum and risk; the current AIQ evidence does not show a clear headline leader.
What is the main difference between NVAX and OCUL?
NVAX and OCUL are close on the current AIQ evidence, so the better fit depends more on objective, risk tolerance and valuation preference than on a single headline score.
AlgovestIQ AIQ Comparison
Novavax, Inc. vs Ocular Therapeutix, Inc.
NVAX and OCUL are effectively level
NVAX and OCUL are effectively level on the AIQ Score; the factor table below shows where each one holds its advantage.
Novavax, Inc.
Ocular Therapeutix, Inc.
The Algovestiq AIQ Score does not currently separate NVAX and OCUL as of Nov 15, 2026. Both names are scored on the same 0–100 scale across Quality, Value, Momentum and Risk Resilience, and the factor table below shows where each one holds its advantage.
Compare Novavax, Inc. and Ocular Therapeutix, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare NVAX and OCUL against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Momentum77 vs 34NVAX +43
- Quality62 vs 42NVAX +20
- Risk Resilience38 vs 36Even
Neither name separates cleanly on the covered dimensions.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Momentum +3
No signal started or stopped since the prior session; its 6 active signals are unchanged.
Largest factor move: Momentum -1, not enough on its own to move the overall score.
New signals
- 52-Week Low Proximity — bearish, risk_regime, long horizon (0.0%)
Deeper signal detail for each name lives on its own signals page — NVAX and OCUL both carry a full feed there.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
EvenNeither separates on the overall score.
Growth
NVAXNVAX on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
NVAXNVAX on the Momentum factor, by 43 points.
Lower downside
OCULOCUL carries the lower 1-month annualized volatility.
Analyst upside
OCULOCUL on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | NVAX | OCUL | Note |
|---|---|---|---|
| Implied upside to target | -6.2% | +125.4% | OCUL has more room |
| Target dispersion | 0% | 0% | Lower is tighter analyst agreement |
| Consensus | Hold | Buy | Context, not a primary driver |
| Analysts covering | 9 | 12 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
How each independent group of evidence reads the pair.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | Not covered | Not covered |
| Fundamentals | NVAXon balance | revenue growth 20.5% vs -4.5%; EPS growth 40.6% vs -20%; TTM ROE 14.5% vs -21.5%; gross margin 77.3% vs 87.3%; operating margin -19.6% vs -6.8% — NVAX takes 3 of 5 decided legs, not all of them |
| Valuation | Not covered | Not covered |
| Technicals | NVAX | Price vs 50-day -19.1% vs -22.3%; vs 200-day -8.7% vs -30.3% |
| Risk Resilience | Even | Risk Resilience 38 vs 36 |
| Analyst expectations | OCUL | Target upside -6.2% vs 125.4% |
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- Only 0 of 4 covered evidence groups agree. (argues the conclusion is provisional)
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 2 bearish / 2 neutral, conflicted
Only NVAX
- Golden Cross Active — bullish, trend, long horizon (12.89%)
- BB Lower Band Breach — bullish, volatility, short horizon
- MACD Histogram Expanding Bearish — bearish, momentum, short horizon
0 bullish / 4 bearish / 2 neutral
Only OCUL
- Death Cross Active — bearish, trend, long horizon (11.42%)
- 52-Week Low Proximity — bearish, risk_regime, long horizon (0.0%)
- Downtrend Structure Active — bearish, trend, long horizon
Both carry 3 more signals that do not separate them: ADX Trend Strengthening, ATR Expansion - Breakout Mode, Beta Spike Warning.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -1.11%, AIQ 0 points).
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
NVAX leads on balance| Metric | NVAX | OCUL |
|---|---|---|
| Revenue growth (YoY) | 20.5% | -4.5% |
| EPS growth (YoY) | 40.6% | -20% |
| Gross margin | 77.3% | 87.3% |
| Operating margin | -19.6% | -6.8% |
| Return on equity (TTM) | 14.5% | -21.5% |
| Debt to equity | -1.36 | 0.18 |
Performance
NVAX leads 4 of 6 windows| Metric | NVAX | OCUL |
|---|---|---|
| 1 week (5 sessions) | -20.9% | -5.8% |
| 1 month (20 sessions) | -24.3% | -9.6% |
| 3 months (63 sessions) | 5.6% | -41.7% |
| 6 months (126 sessions) | -5.9% | -32.2% |
| Year to date | 26.9% | -48.8% |
| 1 year (252 sessions) | 18.4% | -46% |
Technicals
NVAX has the stronger structure| Metric | NVAX | OCUL |
|---|---|---|
| RSI (14) | 37.6 | 37.6 |
| ADX (14) | 24 | 40.4 |
| Price vs 50-day | -19.1% | -22.3% |
| Price vs 200-day | -8.7% | -30.3% |
| Volatility (1M, annualized) | 97.1% | 75.1% |
Risk
Split| Metric | NVAX | OCUL |
|---|---|---|
| Beta | 2.12 | 1.39 |
| Sharpe ratio | 0.56 | -0.45 |
| Sortino ratio | 0.93 | -0.67 |
| Max drawdown | -34.6% | -61.5% |
| Current drawdown | -33.5% | -61.5% |
| Annualized volatility | 73.6% | 76.1% |
| Value at risk (95%) | -6.1% | -6.7% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which has more analyst upside, NVAX or OCUL?
Analyst price targets imply -6.2% upside for NVAX and +125.4% for OCUL, so the Street currently favors OCUL. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, NVAX or OCUL?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, NVAX or OCUL?
NVAX on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, NVAX or OCUL?
NVAX on the Momentum factor, by 43 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, NVAX or OCUL?
OCUL is the more resilient of the two, so the other name carries the higher downside risk. OCUL carries the lower 1-month annualized volatility. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is NVAX more profitable than OCUL?
The profitability evidence is mixed: gross margin 77.3% vs 87.3%; operating margin -19.6% vs -6.8%; ttm roe 14.5% vs -21.5%. NVAX leads on one measure and OCUL on two measures, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
What do the current signals say about NVAX and OCUL?
NVAX: 2 bullish / 2 bearish / 2 neutral, conflicted. OCUL: 0 bullish / 4 bearish / 2 neutral. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on NVAX is Golden Cross Active (bullish, long horizon). On OCUL it is Death Cross Active (bearish, long horizon).
Compare NVAX and OCUL with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.